News

A recent study from the Karolinska Institutet in Sweden has uncovered that both type 2 diabetes and prediabetes can significantly...

Recent research suggests that dark chocolate could be a valuable addition to diets aiming to lower the risk of diabetes...

Embecta Corp. has achieved a significant milestone in diabetes care with the U.S. Food and Drug Administration (FDA) granting 510(k)...

Healthcare providers must evaluate both HbA1c and continuous glucose monitoring (CGM) metrics when managing diabetes, as neither metric alone can...

A new nationwide study reveals that patients with diabetes, particularly those with type 1, face significantly higher rates of sudden...

Be a part of the solution with Breakthrough T1D, the leading global organization dedicated to advancing research and support for...

A recent meta-analysis published in the International Journal of Obesity has demonstrated that Tirzepatide, a novel once-weekly medication, significantly outperforms...

Recent research published in The BMJ indicates that sodium-glucose cotransporter-2 (SGLT-2) inhibitors, a class of diabetes medication, may significantly reduce...

Recent research from the Centenary Institute reveals that specific blood fat markers can forecast how well individuals with pre-diabetes will...

MTPConnect is set to provide a significant boost to Australian small to medium enterprises (SMEs) focusing on innovations in the...

Research indicates that 30 to 70% of individuals with diabetes experience skin manifestations related to their condition, with some cases...

A recent study has revealed that exercise can have different effects on blood glucose levels depending on gender for individuals...

Innovent Biologics, Inc. (HKEX: 01801), a global leader in biopharmaceutical innovation, has announced that it will showcase several clinical trial...

Diabetes has emerged as one of the most pressing health issues worldwide, with its prevalence increasing rapidly and its consequences...

In a groundbreaking clinical trial, tirzepatide, the key ingredient in the weight loss drug Zepbound, has shown a dramatic 94%...

Continuous glucose monitoring (CGM) technology is transforming diabetes management by providing real-time glucose data and reducing the need for frequent...

ype 2 diabetes has long been linked to an increased risk of cognitive decline, with some studies suggesting it doubles...

Glytec, a leader in diabetes and insulin management software, has broadened its partnership with Roche, a prominent pharmaceutical company, to...

Pharmac has announced a major funding initiative that will support the use of continuous glucose monitors (CGMs), insulin pumps, and...

Insulet Corporation, a Massachusetts-based leader in diabetes technology, has received U.S. Food and Drug Administration (FDA) clearance for its Omnipod...